Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Mentice

14,00 SEK

+1,08 %

Mindre end 1K følgere

MNTC

First North Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
+1,08 %
+4,09 %
+4,87 %
+3,70 %
+12,00 %
-34,38 %
-71,65 %
-84,84 %
-79,03 %

Mentice operates in the medical technology sector. The company develops medical instruments for endovascular simulation and for training sessions in surgery. The programs are developed for use in educational purposes among hospitals and institutes. The largest operations are found in North America and Europe. In addition to the main business, opportunities for leasing, support, and technical service are offered. The headquarters are located in Gothenburg.

Læs mere
Markedsværdi
393,76 mio. SEK
Aktieomsætning
63 t SEK
Omsætning
279,09 mio.
EBIT %
-9,88 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
7.5
2026

Delårsrapport Q1'26

26.5
2026

Generalforsamling '26

23.7
2026

Delårsrapport Q2'26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelse27.2.2026, 07.19

DNB Carnegie Access: Mentice: Ending 2025 on a high note – Q4 review

Mentice
Selskabsmeddelelse26.2.2026, 20.00

Communique from extraordinary shareholders’ meeting in Mentice AB

Mentice
Pressemeddelelse26.2.2026, 07.17

DNB Carnegie Access: Mentice: Firing on all cylinders – Q4 initial take

Mentice

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse26.2.2026, 06.00

Mentice publishes the company’s year-end report for the period January–December 2025

Mentice
Pressemeddelelse12.2.2026, 14.00

Mentice to Present the Company's Year-End Q4 Report 2025 via Webcast

Mentice
Selskabsmeddelelse3.2.2026, 14.52

Notice to attend the extraordinary shareholders’ meeting in Mentice AB

Mentice
Pressemeddelelse8.1.2026, 07.42

DNB Carnegie Access: Mentice: Look beyond FX headwinds – Q4 preview

Mentice
Pressemeddelelse7.11.2025, 06.32

DNB Carnegie Access: Mentice: Starting to show strong operating leverage – Q3 review

Mentice
Pressemeddelelse6.11.2025, 07.45

DNB Carnegie Access: Mentice: Shows strong operational leverage – Q3 initial take

Mentice
Selskabsmeddelelse6.11.2025, 06.00

Mentice publishes the company’s interim report for the period July – September 2025

Mentice
Selskabsmeddelelse23.10.2025, 13.30

Nomination Committee has been appointed for Mentice AB (publ) Annual General Meeting 2026

Mentice
Pressemeddelelse23.10.2025, 07.00

Mentice to Present Q3 2025 Interim Report via Webcast

Mentice
Pressemeddelelse3.10.2025, 06.53

DNB Carnegie Access: Mentice: Cost-control focus – Q3 preview

Mentice
Pressemeddelelse21.8.2025, 06.15

Mentice receives approximately SEK 31.95 million through oversubscribed rights issue

Mentice
Pressemeddelelse4.8.2025, 13.00

Mentice publishes information document regarding rights issue

Mentice
Pressemeddelelse1.8.2025, 11.00

Mentice receives an additional Subscription Commitment of 3.4 MSEK in the upcoming Rights Issue

Mentice
Pressemeddelelse25.7.2025, 07.53

DNB Carnegie Access: Mentice: Shows resilience in adj. EBITDA – Q2 review

Mentice
Pressemeddelelse24.7.2025, 11.05

DNB Carnegie Access: Mentice: Recording from earnings call Q2 (25)

Mentice
Pressemeddelelse24.7.2025, 07.07

DNB Carnegie Access: Mentice: FX and comparables tougher than feared – Q2 initial take

Mentice
Selskabsmeddelelse24.7.2025, 06.00

Mentice resolves on a rights issue of approximately SEK 31.95 million

Mentice
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.